Clinical TraininG
Year 1: Clinical training
Years 2 (3 optional): Focused research training and continuity clinics
Our clinical training program has multiple outpatient and inpatient sites to fulfill cross-training requirements in adult and pediatric AI.
Fellows individualize their training using:
- Diverse clinic populations
- Extensive subspecialty electives
- Formal didactics
- Mentored scholarly activity
Fellows gain exposure to the most severe/complex cases of asthma, rhinosinusitis, drug/food/venom allergy, anaphylaxis, immunodeficiency, systemic mastocytosis, and eosinophilic disorders and become experts in outpatient food and drug challenges and aspirin and other drug desensitizations.
Our program is a national referral center for pediatric and adult patients with primary immunodeficiency disorders (PIDD) and fellows become proficient in the evaluation and treatment of patients with PIDD including use of IVIG, immunomodulators, and bone marrow transplantation for severe combined immune deficiencies (SCID) or SCID-like disorders.
Conferences
Educational conferences are a key learning feature of our training program. Fellows participate in a variety of educational sessions as described in our Education page. They are expected to attend the regional Washington State Society of Allergy, Asthma, and Immunology (WSSAAI) Northwest Allergy Forum and national American Academy of Allergy, Asthma & Immunology (AAAAI) Meeting and are expected to present their work when it is sufficiently mature.

Scholarly and QI Activities
Fellows are expected to complete a scholarly project and participate in QI activities during their training. Fellows present their findings at local, national, or international meetings, and publish in peer-reviewed publications (case reports, review articles, and chapters).
Clinical Projects Completed by Fellows
- Case report: Hypereosinophilic syndrome presenting as coagulopathy (Aukstulolis K 2022)
- Review: Omalizumab for Chronic Urticaria in Children Less than 12 Years of Age (Al-Shaikhly T, 2019)
- Case Report: Immunodeficiency in MIRAGE Syndrome (Patel JP, 2017)
- Case Report: IKBA Gain-of-Function Mutation in a Female Presenting With Infections and Hyper IgM, but Without Ectodermal Dysplasia (Swanson C, 2017)
- Review: Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis (Lenington J, 2017)
- Review: From clinical observations and molecular dissection to novel therapeutic strategies for primary immunodeficiency disorders (Petroni D, 2017)
- Review: Approach to the evaluation of adverse antibiotic reactions in patients with cystic fibrosis (Petroni D, 2016)
- Chapter: Lipid Mediators in Aspirin-Exacerbated Respiratory Disease (Parker AR, 2016)
- Chapter: Hematopoietic Stem Cell Transplant for Immune Deficiency and Immune Dysregulation Disorders (Hagin D, 2015)
- Chapter: Primary immunodeficiency disorders: classification, new molecular insights, and approach to diagnosis and treatment (Hagin D, 2014)
- Case Report: Successful desensitization to rosuvastatin in a patient with a history of anaphylaxis to multiple statins (Khan FS, 2013)